Webinar Now Available: Making sense of anti-sense oligo facility planning
Nov 4, 2019
The presentation addresses why a facility’s balance between supporting initial product demand and future projections is essential. One of the great advantages of solid phase oligonucleotide synthesis is its scalability. Jake Adams, Bill Jarvis and Brendan Nichols discussed how to right-size a facility for current needs, but minimize the facility impact of an increase in manufacturing throughput to take advantage of the synthesis platform’s scalability.
The presentation will equip attendees with how to swiftly devise a facility layout using a starting batch size/throughput and a projected batch size/throughput, considering applicable code implications.